These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4826582)

  • 1. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
    Hrushesky WJ; Murphy GP
    J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
    Murphy GP; Williams PD
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
    [No Abstract]   [Full Text] [Related]  

  • 3. Lomustine treatment of metastatic renal cell carcinoma.
    Mittelman A; Albert DJ; Murphy GP
    JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of advanced renal cell carcinoma with vinblastine and CCNU.
    Merrin C; Mittelman A; Fanous N; Walsman Z; Murphy GP
    J Urol; 1975 Jan; 113(1):21-3. PubMed ID: 1113389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
    Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
    Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea.
    von Eyben F; Mattsson W; Glifberg I; Lindholm CE
    J Urol; 1979 Mar; 121(3):367-8. PubMed ID: 430637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of the therapy of advanced renal carcinoma.
    Hrushesky WJ; Murphy GP
    J Surg Oncol; 1977; 9(3):277-88. PubMed ID: 327158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined drug therapy in transplanted colonic mice tumors].
    Double JA; Cifuentes de Castro L; Lee PW
    Rev Clin Esp; 1979 Dec; 155(5):335-8. PubMed ID: 545477
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
    Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
    Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma carcinoembryonic antigen in renal cell carcinoma patients.
    Chu TM; Shukla SK; Mittleman AO; Murphy GP
    J Urol; 1974 Jun; 111(6):742-4. PubMed ID: 4830874
    [No Abstract]   [Full Text] [Related]  

  • 14. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
    Hasegawa H; Shapiro WR; Posner JB; Basler G
    Cancer Res; 1979 Jul; 39(7 Pt 1):2687-90. PubMed ID: 445472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of renal cell carcinoma. 2. Combined chemotherapy using ACNU and VBL].
    Kobayashi M; Imai K; Nakai K; Kumasaka F; Suzuki T; Ito Y; Yamanaka H; Sugihara S
    Hinyokika Kiyo; 1986 Mar; 32(3):375-83. PubMed ID: 3460318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic studies of a transplantable murine renal adenocarcinoma.
    Sufrin G; Murphy GP
    Invest Urol; 1977 Jul; 15(1):9-14. PubMed ID: 68945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of effective vinblastine-sulfate dosage in different renal cell carcinomas after transplantation to the NU/NU mice.
    Otto U; Huland H; Klosterhalfen H
    Prog Clin Biol Res; 1982; 100():209. PubMed ID: 7145946
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.